JASMINE SHARIFAN: Open Payments
NPI 1205449402 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 70 payments from 19 companies in 2025. Trend: 2023 $626 · 2024 $1,355 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $224 |
| ABBVIE INC. | 9 | $157 |
| BETA BIONICS, INC. | 6 | $129 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Lilly USA, LLC | 4 | $79 |
| Dexcom, Inc. | 4 | $78 |
| Novo Nordisk Inc | 4 | $78 |
| Madrigal Pharmaceuticals | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Ascensia Diabetes Care Us Inc. | 3 | $60 |
Products named: MINIMED 780G, SYNTHROID, iLet Bionic Pancreas, MOUNJARO, Dexcom G6 Transmitter, RECORLEV, REZDIFFRA, CRENESSITY.
Industry payments across UT — which companies pay providers there.
